Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections. (Record no. 27906425)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01334 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517192153.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201802s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1744-7607 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1080/17425255.2018.1420162 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Galluzzo, M |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180222 |
245 00 - TITLE STATEMENT | |
Title | Pharmacokinetic drug evaluation of dalbavancin for the treatment of skin infections. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Expert opinion on drug metabolism & toxicology |
Date of publication, distribution, etc. | Feb 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 197-206 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Anti-Bacterial Agents |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cost Savings |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gram-Positive Bacterial Infections |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hospitalization |
General subdivision | statistics & numerical data |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Length of Stay |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Diseases, Bacterial |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Teicoplanin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vancomycin |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | D'Adamio, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bianchi, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Talamonti, M |
773 0# - HOST ITEM ENTRY | |
Title | Expert opinion on drug metabolism & toxicology |
Related parts | vol. 14 |
-- | no. 2 |
-- | p. 197-206 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1080/17425255.2018.1420162">https://doi.org/10.1080/17425255.2018.1420162</a> |
Public note | Available from publisher's website |
No items available.